VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by US Bancorp DE

US Bancorp DE cut its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 53.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 873 shares of the company’s stock after selling 983 shares during the quarter. US Bancorp DE’s holdings in VanEck Pharmaceutical ETF were worth $75,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in PPH. Activest Wealth Management acquired a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at $32,000. FMR LLC increased its holdings in VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after purchasing an additional 212 shares during the period. Townsquare Capital LLC increased its holdings in VanEck Pharmaceutical ETF by 3.8% during the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after purchasing an additional 130 shares during the period. Grimes & Company Inc. acquired a new stake in VanEck Pharmaceutical ETF in the 4th quarter valued at about $310,000. Finally, Elm3 Financial Group LLC purchased a new position in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at about $324,000.

VanEck Pharmaceutical ETF Stock Performance

Shares of VanEck Pharmaceutical ETF stock opened at $93.29 on Tuesday. The business has a 50-day simple moving average of $89.72 and a 200-day simple moving average of $91.08. VanEck Pharmaceutical ETF has a one year low of $84.48 and a one year high of $99.51. The company has a market cap of $582.13 million, a PE ratio of 30.55 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently declared a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were issued a dividend of $0.411 per share. The ex-dividend date of this dividend was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.